# Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B

> **NCT02533544** · — · COMPLETED · sponsor: **Myeong Jun Song** · enrollment: 572 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** tenofovir disoproxil fumarate

## Key facts

- **NCT ID:** NCT02533544
- **Lead sponsor:** Myeong Jun Song
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 572 (ACTUAL)
- **Last updated:** 2019-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02533544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02533544, "Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02533544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*